Photrexa
Drug
Avedro Inc.
Total Payments
$2.3M
Transactions
1,958
Doctors
1,422
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $46,186 | 645 | 535 |
| 2020 | $445,794 | 871 | 642 |
| 2019 | $1.1M | 13 | 0 |
| 2018 | $687,513 | 429 | 321 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.1M | 98 | 91.5% |
| Food and Beverage | $111,237 | 1,814 | 4.9% |
| Consulting Fee | $81,805 | 39 | 3.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $700.00 | 2 | 0.0% |
| Travel and Lodging | $356.20 | 5 | 0.0% |
Payments by Type
Research
$2.1M
98 transactions
General
$194,099
1,860 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| KXL-308 | Avedro Inc. | $583,590 | 0 |
| 308 | Avedro Inc. | $553,503 | 0 |
| 308 & 401 | Avedro Inc. | $540,531 | 0 |
| A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus | Glaukos Corporation | $306,130 | 0 |
| A Phase IV Observational Registry to Assess the Safety and Durability of Effect of Corneal Collagen Cross-linking With Photrexa Viscous, Photrexa, and the KXL System in Patients With Corneal Ectasia Following Refractive Surgery | Glaukos Corporation | $68,010 | 0 |
| KXL-401 | Avedro Inc. | $27,665 | 0 |
| 308 Study | Avedro Inc. | $15,485 | 0 |
Top Doctors Receiving Payments for Photrexa
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Westerville, OH | $2.1M | 98 |
| , M.D | Ophthalmology | Waltham, MA | $12,087 | 10 |
| , MD | Ophthalmology | Sioux Falls, SD | $10,875 | 1 |
| , M.D | Ophthalmology | Minneapolis, MN | $8,000 | 1 |
| , MD | Ophthalmology | Bala Cynwyd, PA | $6,552 | 6 |
| , MD | Ophthalmology | Overland Park, KS | $6,100 | 1 |
| , MD | Ophthalmology | Boston, MA | $4,096 | 4 |
| , MD | Ophthalmology | Seattle, WA | $3,771 | 3 |
| , MD | Ophthalmology | Westerville, OH | $2,943 | 3 |
| , M.D | Ophthalmology | Sioux Falls, SD | $2,380 | 3 |
| , M.D | Ophthalmology | Minneapolis, MN | $2,350 | 1 |
| , MD | Ophthalmology | Philadelphia, PA | $2,281 | 2 |
| , O.D | Optometrist | Sioux Falls, SD | $2,130 | 6 |
| , MD | Ophthalmology | Cleveland, OH | $2,000 | 1 |
| , M.D | Ophthalmology | Sioux Falls, SD | $2,000 | 1 |
| , M.D | Ophthalmology | Sioux Falls, SD | $1,894 | 3 |
| , MD | Cornea and External Diseases Specialist | Stanford, CA | $1,789 | 2 |
| , M.D | Ophthalmology | Sioux Falls, SD | $1,758 | 2 |
| , O.D | Optometrist | Sunnyvale, CA | $1,739 | 7 |
| , M.D | Ophthalmology | Sioux Falls, SD | $1,500 | 1 |
| , M.D | Ophthalmology | Westlake Village, CA | $1,190 | 5 |
| , O.D | Optometrist | Honolulu, HI | $1,055 | 1 |
| , MD | Pediatric Ophthalmology and Strabismus Specialist | Kansas City, MO | $1,000 | 1 |
| , MD | Ophthalmology | Evanston, IL | $1,000 | 2 |
| , MD | Ophthalmology | Pennington, NJ | $750.00 | 1 |
Ad
Manufacturing Companies
- Avedro Inc. $1.8M
- Glaukos Corporation $491,980
Product Information
- Type Drug
- Total Payments $2.3M
- Total Doctors 1,422
- Transactions 1,958
About Photrexa
Photrexa is a drug associated with $2.3M in payments to 1,422 healthcare providers, recorded across 1,958 transactions in the CMS Open Payments database. The primary manufacturer is Avedro Inc..
Payment data is available from 2018 to 2024. In 2024, $46,186 was paid across 645 transactions to 535 doctors.
The most common payment nature for Photrexa is "Unspecified" ($2.1M, 91.5% of total).
Photrexa is associated with 7 research studies, including "KXL-308" ($583,590).